ALKBH5 and intrahepatic cholangiocarcinoma: In intrahepatic cholangiocarcinoma (ICC), the m6A demethylase ALKBH5 has been shown to diminish m6A methylation on PD-L1 mRNA, shielding it from YTHDF2-mediated degradation.